Yael Mansour

Yael Mansour brings deep experience across law, life sciences and business. With a foundation in biochemistry and pharmacology, she provides a rare combination of scientific understanding coupled with legal and strategic insight — helping clients navigate the complex landscape governing access to medicine, innovation, and regulatory compliance.

Before founding Cura Law™, Yael practiced at one of Canada’s prestigious international law firms as part of a top-ranked intellectual property team, representing global generic pharmaceutical manufacturers in high-stakes patent litigation. She later joined an industry-leading global innovator company as in-house counsel.

She has also lectured in the Biotechnology and Issues in Health Law course in the LLM program at York University’s Osgoode Hall Law School.

Yael has appeared before the Federal Court and Federal Court of Appeal, and has provided counsel before Health Canada, the Patented Medicine Prices Review Board (PMPRB), the Pharmaceutical Advertising Advisory Board (PAAB), and Innovative Medicines Canada (IMC).

Having worked across both innovator and generic sectors, Yael understands what drives progress – the science, the commercial drivers, and the regulatory frameworks that underpin the entire product lifecycle. Yael leverages her scientific, legal, and business insight to anticipate change, assess risk and provide forward-looking guidance. She is guided by a belief that thoughtful legal advice can both protect innovation and expand access to medicines.

Through Cura Law™, Yael helps organizations navigate Canada’s pharmaceutical legal and policy landscape with clarity, judgment, and practical insight.